[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Rxsight Inc (RXST)

Rxsight Inc (RXST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 217,334
  • Shares Outstanding, K 41,397
  • Annual Sales, $ 134,480 K
  • Annual Income, $ -38,940 K
  • EBIT $ -55 M
  • EBITDA $ -61 M
  • 60-Month Beta 1.15
  • Price/Sales 1.51
  • Price/Cash Flow N/A
  • Price/Book 0.76

Options Overview Details

View History
  • Implied Volatility 224.89% (+81.62%)
  • Historical Volatility 67.19%
  • IV Percentile 57%
  • IV Rank 25.53%
  • IV High 673.85% on 03/30/26
  • IV Low 70.99% on 08/18/25
  • Expected Move (DTE 36) 0.94 (16.94%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 109
  • Volume Avg (30-Day) 97
  • Put/Call OI Ratio 0.80
  • Today's Open Interest 1,667
  • Open Int (30-Day) 1,310
  • Expected Range 4.63 to 6.51

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.37
  • Number of Estimates 5
  • High Estimate $-0.31
  • Low Estimate $-0.40
  • Prior Year $-0.29
  • Growth Rate Est. (year over year) -27.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.56 +22.15%
on 06/17/26
5.93 -6.07%
on 07/16/26
+0.89 (+19.02%)
since 06/16/26
3-Month
4.48 +24.33%
on 06/11/26
7.72 -27.85%
on 04/17/26
-1.81 (-24.53%)
since 04/16/26
52-Week
4.48 +24.33%
on 06/11/26
13.22 -57.87%
on 12/11/25
-1.71 (-23.49%)
since 07/16/25

Most Recent Stories

More News
RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer

ALISO VIEJO, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced a planned leadership transition effective July 20, 2026, with Aziz Mottiwala appointed President and...

RXST : 5.57 (+6.10%)
Glancy Prongay Wolke & Rotter LLP Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors

Glancy Prongay Wolke & Rotter LLP , a leading national shareholder rights law firm, today announced that it is investigating potential claims against the board of directors of RxSight, Inc. (“RxSight”...

RXST : 5.57 (+6.10%)
Law Offices of Howard G. Smith Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors

Law Offices of Howard G. Smith announces it is investigating potential claims against the board of directors of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST ) concerning...

RXST : 5.57 (+6.10%)
The Law Offices of Frank R. Cruz Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors

The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST ) concerning...

RXST : 5.57 (+6.10%)
Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs

Non-exclusive license agreement for the development and commercialization of novel post-operative light adjustable PCIOL technologies ...

RXST : 5.57 (+6.10%)
ALC : 70.62 (+3.09%)
Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs

Non-exclusive license agreement for the development and commercialization of novel post-operative light adjustable PCIOL technologies Collaboration aims to combine best-in-class PCIOL optics with first-in-class...

RXST : 5.57 (+6.10%)
ALC : 70.62 (+3.09%)
RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement

ALISO VIEJO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced select preliminary financial results for the second quarter of 2026 and updates to its standalone product...

RXST : 5.57 (+6.10%)
Did RxSight, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...

RXST : 5.57 (+6.10%)
RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum

ALISO VIEJO, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., today announced plans to participate in the upcoming Stifel 2026 Virtual Ophthalmology Forum. Management is scheduled...

RXST : 5.57 (+6.10%)
RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

ALISO VIEJO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter ended March 31, 2026. Strategic Highlights and Recent Developments...

RXST : 5.57 (+6.10%)

Business Summary

RxSight Inc. is a commercial-stage medical technology company focuses on patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens(R), RxSight Light Delivery Device and accessories. RxSight Inc. is based in ALISO VIEJO, Calif.

See More

Key Turning Points

3rd Resistance Point 6.85
2nd Resistance Point 6.39
1st Resistance Point 5.98
Last Price 5.57
1st Support Level 5.11
2nd Support Level 4.65
3rd Support Level 4.24

See More

52-Week High 13.22
Fibonacci 61.8% 9.88
Fibonacci 50% 8.85
Fibonacci 38.2% 7.82
Last Price 5.57
52-Week Low 4.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.